Antithrombin binding by human umbilical vein endothelial cells: Effects of exogenous heparin
- 1 July 1995
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 79 (2) , 175-186
- https://doi.org/10.1016/0049-3848(95)00103-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.The Journal of cell biology, 1990
- Role of Endothelial Cell Surface Heparin-like PolysaccharidesAnnals of the New York Academy of Sciences, 1989
- Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell culturesBiochemistry, 1988
- Characterization and N-terminal sequence of a heparan sulphate proteoglycan synthesized by endothelial cells in cultureBiochemical Journal, 1987
- Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cellsExperimental Cell Research, 1987
- Biosynthesis of heparinTrends in Biochemical Sciences, 1986
- Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1985
- Human adult endothelial cell growth in cultureJournal of Vascular Surgery, 1984
- Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial CultivationScience, 1983
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973